#genetherapy
How science breakthroughs in 2025 reshaped medicine, space research, and climate reality
A century ago, the notion of restoring lost senses or detecting ancient life beyond Earth belonged firmly to science fiction. In 2025, such ideas moved decisively into reality as a series of scientific breakthroughs reshaped long-standing assumptions across medicine, space science, climate research, and artificial intelligence. These advances did not arrive as distant promises or speculative theories, but as working solutions that delivered measurable results and altered how science interacts
How science breakthroughs in 2025 reshaped medicine, space research, and climate reality
A century ago, the notion of restoring lost senses or detecting ancient life beyond Earth belonged firmly to science fiction. In 2025, such ideas moved decisively into reality as a series of scientific breakthroughs reshaped long-standing assumptions across medicine, space science, climate research, and artificial intelligence. These advances did not arrive as distant promises or speculative theories, but as working solutions that delivered measurable results and altered how science interacts
India plans major price cuts for cancer, HIV, and rare disease drugs with customs duty waiver
In a major development that could bring relief to thousands of patients across India, the central government is preparing to slash prices of critical and life-saving medicines, particularly those used to treat cancer, HIV, and rare genetic disorders. A recently accessed official document reveals that an interdepartmental committee has recommended a set of sweeping customs duty exemptions and concessions aimed at making high-cost medical treatments more accessible to Indian patients.
India plans major price cuts for cancer, HIV, and rare disease drugs with customs duty waiver
In a major development that could bring relief to thousands of patients across India, the central government is preparing to slash prices of critical and life-saving medicines, particularly those used to treat cancer, HIV, and rare genetic disorders. A recently accessed official document reveals that an interdepartmental committee has recommended a set of sweeping customs duty exemptions and concessions aimed at making high-cost medical treatments more accessible to Indian patients.









